Drug
Typhim VI
Typhim VI is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
25%
Ph phase_1
3
75%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
3(75.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Early Phase 11 (25.0%)
Phase 13 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
Effects of Aging on Primary and Secondary Vaccine Responses
NCT03312699
completedearly_phase_1
Persistent Readiness Through Early Prediction Immunization Study
NCT05346302
completedphase_1
Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine
NCT02645032
completedphase_1
Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults
NCT03956524
Clinical Trials (4)
Showing 4 of 4 trials
NCT03312699Phase 1
Effects of Aging on Primary and Secondary Vaccine Responses
NCT05346302Early Phase 1
Persistent Readiness Through Early Prediction Immunization Study
NCT02645032Phase 1
Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine
NCT03956524Phase 1
Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4